You use Therapeutics in Dermatology on a regular basis and you are pleased with it?
We need your help to keep this free tool alive!

make a donation here !


6 June 2012, by DELAPORTE E. & PIETTE F.


Sulfasalazine (Salazopyrin®) was launched in France en 1958. Its current indications are: ulcerative colitis, colic Crohn’s disease and rheumatoid arthritis. This molecule has few uses in a dermatological setting.

× N.B. : This limited content is for the general public. If you are a health professional, click here to register for free and gain access to a dedicated deeper content.
If you already have an account, log in!

Follow us


  Health professionals

The other websites of the foundation